Found 2,855 investors
ACI Capital
United States
Founded in 1995, ACI Capital is a private equity firm based in New York, New York. The firm seeks to make control investments in middle-market firms operating in the consumer products, restaurants, niche manufacturing, transportation, healthcare services, financial services, logistics and media sectors.
Private Equity Firm
A-Companies
United States
Founded in 2006, A-Companies is a private equity firm based in Portland, Oregon. The firm seeks to invest in healthcare, real estate, and manufacturing sectors.
Private Equity Firm
Acquire One
United States
Founded in 2007, Acquire One is a private equity firm based in Detroit, Michigan. The firm seeks to invest in small-cap middle-market companies based in North America. The firm seeks to invest in the healthcare, media, information services, and manufacturing sectors.
Private Equity Firm
Action Equity
United States
Founded in 2006, Action Equity is a venture capital firm based in Portland, United States. The firm seeks to invest in IT services and healthcare opportunities sectors.
Venture Capital
Adagia Partners
France
Founded in 2020, Adagia Partners is a pan-European mid-market private equity firm based in Paris, France. The firm seeks to invest in mid-cap companies operating in the healthcare, business services, artificial intelligence and tech industrials sectors based in France, Germany, Benelux, Switzerland and Austria.
Private Equity Firm
Adam Katz
Australia
Dr. Alan Taylor is a Co-Founder and serves as Chairman at Mizzenit. He has a background as a scientist, investment banker, entrepreneur and investor. He is currently very active in the Australian start-up area, investing in, advising and taking an active role within a number of early stage companies. Alan is currently the Chairman and co-founder of Mizzen Group Pty Ltd, a new technology start-up company in the transport and logistics area. Alan is also the the Executive Chairman at Clarity Pharmaceuticals, a company focused on developing radiopharmaceuticals for the treatment of cancer and other diseases. Alan is passionate about the commercialisation of Australian science and technologies, either in general technology or the life sciences. Alan has approximately 10 years of investment banking experience, and was until recently an Executive Director and shareholder of Inteq Limited, a boutique Australian investment bank, where he remains on the Board of Directors. Alan has significant experience in capital raisings, mergers and acquisitions, and general corporate advisory. He has experience across a broad range of industries including healthcare and life sciences, technology, and resources. Alan is also a lecturer at the University of Sydney, lecturing to Masters of Commerce and International Business students undertaking studies in New Business Opportunities and Start-ups. Alan completed an undergraduate degree in Applied Science at the University of Sydney, where he finished first in his year and won the prestigious University Medal. He completed his Ph.D. in Medicine at the Garvan Institute of Medical Research, where he investigated the molecular mechanisms of skeletal muscle insulin resistance. Alan has also completed a Graduate Diploma in Applied Finance at the Securities Institute of Australia.
Individual/Angel
Adam Rogers
United States
Mr. Guy Miasnik serves as Angel Investor at Guy Miasnik. He served as Chief Strategy Officer at Blackberry. In his role, Guy translates BlackBerry's vision for the Enterprise of Things into integrated offerings and go-to-market strategies that drive sustainable growth across BlackBerry's business units. He serves as Advisor at Hidden Level. Prior to February 2017, Guy was President of AtHoc, the crisis communication Division of BlackBerry that was formed after AtHoc was acquired in 2015. As the co-founder and CEO of AtHoc, Guy transformed the business from a Greylock-funded Silicon Valley startup to a profitable, high-growth leader in the crisis communication market serving the vast majority of the US Homeland Security and Defense community. Today, BlackBerry AtHoc software helps safeguard millions of people worldwide in commercial, healthcare and government organizations. Prior to AtHoc, Guy co-founded and served as CEO at Kinetica Ltd., a technology services company, where he drove the firm's growth from a zero-capital start-up to profitability in less than two years. It was later acquired by NetVision. Guy earned his MBA at Harvard Business School and B.Sc. in Electrical Engineering (summa cum laude) from the Technion. He holds eight patents in crisis communication. Guy is an active member of the Pacific Council on International Policy, serves on the advisory board of the Harvard Business School Center of Entrepreneurship Rock 100 Summit, and has been serving on the boards of several educational nonprofit organizations.
Individual/Angel
Adaptive Healthcare Fund
Los Angeles, California, United States
Adaptive Healthcare Fund provides financial and strategic support to healthcare entrepreneurs with a focus on opportunities driven.
Private Equity Firm
Addor Capital
China
Addor Capital is a venture capital and private equity investment firm that seeks to invest in companies based in China. The firm prefers to invest in the clean technology, healthcare, logistics, materials, semiconductors, TMT, and consumer sectors.
Growth Capital
Adele C. Oliva
Philadelphia, Pennsylvania, United States
Ms. Oliva joined Quaker Partners, a healthcare venture capital and growth equity firm, as a Partner in 2007. Before joining Quaker, Ms. Oliv...
Investment Partner
Ader Finance
Paris, Ile-de-France, France
Ader Finance is a capital raising, IPO and M&A advisor in France serving IT, communication, greentech, healthcare, and digital media.
Financial Services
FinTech
Health Care
Venture Capital
Venture Capital
ADER Investissements
India
Ms. Ameera Shah serves as Promoter,Board Member & Managing Director at Metropolis Healthcare. She is also an Angel Investor. Ms. Shah has evolved Metropolis from its single pathology laboratory status to a fully integrated multinational chain of 125 diagnostic centers and 800 collection centers across the globe. Metropolis delivers over 15 million tests a year, catering to more than 10,000 Laboratories, Hospitals, Nursing homes and 2,00,000 Consultants. With 33 years of experience in delivering accurate reports, Metropolis has earned the reputation of being India's leading and only multinational chain of diagnostic centers with presence in UAE, Sri Lanka, South Africa, Kenya, Mauritius and Ghana. She has revolutionized the pathology industry from being a doctor led practice to a professional corporate group in an extremely unregulated, competitive and fragmented market. Under her leadership, Metropolis has been the first to create a sustainable business model for pathology, the first to traverse in to emerging markets & the first to implement global standards of quality in all its processes & systems. Ms. Shah received a degree in Finance from The University of Texas at Austin and has also completed the prestigious Owner-President Management Program at Harvard Business School. Ms. Shah is an eminent industry spokesperson and has been featured as a speaker in various National and International forums, industry events and conclaves. She has been a key-speaker at prestigious events organized by IIM- Ahmedabad, Harvard Business School, CII and many such reputed institutions. She has also been elected the Secretary of the IAPL (Indian Association of Pathology Laboratories) and is the Chairperson of the 'FICCI Health services Western Subgroup' that drives policy decisions at the Center. Ms. Shah is an independent director on the board of several reputed companies and she is also an adviser to many educational institutions. An International & National award winner, She was conferred with 'The Young entrepreneur of the Year Award' by GE in 2006 and 'The Young Achiever of the Year Award' at the CMO Asia Awards in 2011. She was also the recipient of the prestigious 'Young Entrepreneur of the Year Award' in 2011 organized by Entrepreneur India and Bloomberg. She has been honored with 'Exemplary Women Leadership award' at the World Women Leadership and Congress awards 2014. Recently she has been chosen as one of the most respected leaders under 40 years by Economic Times & Spencer Stuart (2014).
Individual/Angel
Adetunji Eleso
Sweden
Mr. Thomas Eklund serves as Industrial Partner at Impilo. He served as Managing Director at Investor Growth Capital. He joined the Investor Growth Capital Europe team as Managing Director in 2002 and has served as Head of the Stockholm office since 2006. He focuses on expansion-stage investments in device and pharmaceutical companies and has been responsible for investments in Carmel Pharma, Swedish Orphan International, and Entific Medical Systems. Prior to joining IGC, he spent two years as Investment Director of ABN Amro Capital Investments where he was responsible for investment processing of expansion capital and MBO transactions in the Nordic region. Investments managed during his time at ABN Amro include MBOs of Champion Inc. and Biovitrum AB. In addition, He served a Vice President of the healthcare group at Handelsbanken Securities Corporate Finance. He received an M.B.A. from the Stockholm School of Economics.
Individual/Angel
Adidev Ventures
United States
Founded in 2020, Adidev Ventures is an investment firm based in Bloomington, Illinois. The firm prefers to invest in the healthcare, logistics, transportation, data science, real estate, food and beverage, robotics, industrials, real estate, life science, digital health and other information technology sectors.
Private Equity Firm
Advent-Morro Equity Partners
San Juan, Manila, Philippines
Based in Puerto Rico, Advent-Morro Equity Partners focuses on healthcare, distribution, technology, telecom, education, and hospitality.
CleanTech
Finance
Health Care
Private Equity Firm
AEA Growth
United States
AEA Growth is a growth equity investment firm based in San Francisco, California. The firm seeks to invest in tech-enabled businesses, software, and healthcare sectors.
Growth Capital
Aegis Ventures
United States
Aegis Ventures is a venture studio based in New York, New York. The firm seeks to invest in the healthcare, wellness, digital health, and health tech sectors.
Venture Capital
Aerie Specialty Finance
United States
Founded in 2013, Aerie Specialty Finance is an investment firm and is based in Manhattan Beach, California. The firm provides growth capital to lower middle-market companies operating in the healthcare, information technology, biotechnology and life science sectors.
Growth Capital
Aeterna
Switzerland
Aeterna AG is an investment firm that specializes in the medium-sized growth capital investments. The firm is primarily based in Baar, Switzerland and prefers to invest in the manufacturing, consumer goods, TMT and healthcare sectors.
Growth Capital
Aexea
United Kingdom
Aexea is a private equity firm based in London, United Kingdom. The firm seeks to invest in the SaaS, healthcare, and manufacturing sectors.
Private Equity Firm
Showing 221 to
240 of
2,855 results